Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 9—September 2022
Dispatch

Creutzfeldt-Jakob Disease Incidence, South Korea, 2001–2019

Yong-Chan Kim and Byung-Hoon JeongComments to Author 
Author affiliation: Jeonbuk National University, Jeonju, South Korea

Main Article

Figure 2

Creutzfeldt-Jakob disease (CJD) incidence, South Korea and globally, 2001–2019. A) Number of cases and incidence per million persons in cities and provinces of South Korea, including probable, possible, and definite CJD diagnoses. B) Global number of sporadic CJD cases and incidence per million population by country (4). Sporadic CJD incidence for South Korea is from this study.

Figure 2. Creutzfeldt-Jakob disease (CJD) incidence, South Korea and globally, 2001–2019. A) Number of cases and incidence per million persons in cities and provinces of South Korea, including probable, possible, and definite CJD diagnoses. B) Global number of sporadic CJD cases and incidence per million population by country (4). Sporadic CJD incidence for South Korea is from this study.

Main Article

References
  1. Prusiner  SB. The prion diseases. Brain Pathol. 1998;8:499–513. DOIPubMedGoogle Scholar
  2. Prusiner  SB. Prions. Proc Natl Acad Sci U S A. 1998;95:13363–83. DOIPubMedGoogle Scholar
  3. Kim  YC, Won  SY, Jeong  BH. Altered expression of glymphatic system-related proteins in prion diseases: Implications for the role of the glymphatic system in prion diseases. Cell Mol Immunol. 2021;18:2281–3. DOIPubMedGoogle Scholar
  4. Uttley  L, Carroll  C, Wong  R, Hilton  DA, Stevenson  M. Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation. Lancet Infect Dis. 2020;20:e2–10. DOIPubMedGoogle Scholar
  5. Asante  EA, Linehan  JM, Desbruslais  M, Joiner  S, Gowland  I, Wood  AL, et al. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J. 2002;21:6358–66. DOIPubMedGoogle Scholar
  6. Mastrianni  JA. The genetics of prion diseases. Genet Med. 2010;12:187–95. DOIPubMedGoogle Scholar
  7. Collinge  J, Palmer  MS, Dryden  AJ. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet. 1991;337:1441–2. DOIPubMedGoogle Scholar
  8. Kovács  GG, Puopolo  M, Ladogana  A, Pocchiari  M, Budka  H, van Duijn  C, et al.; EUROCJD. Genetic prion disease: the EUROCJD experience. Hum Genet. 2005;118:166–74. DOIPubMedGoogle Scholar
  9. Jeong  BH, Kim  YS. Genetic studies in human prion diseases. J Korean Med Sci. 2014;29:623–32. DOIPubMedGoogle Scholar
  10. World Health Organization. WHO infection control guidelines for transmissible spongiform encephalopathies. Geneva: The Organization; 2000.
  11. Chandra  S, Mahadevan  A, Shankar  SK. Familial CJD—brief commentary. Ann Indian Acad Neurol. 2019;22:462–3.PubMedGoogle Scholar
  12. Arata  H, Takashima  H. [Familial prion disease (GSS, familial CJD, FFI)]. Nihon Rinsho. 2007;65:1433–7.PubMedGoogle Scholar

Main Article

Page created: July 31, 2022
Page updated: August 19, 2022
Page reviewed: August 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external